文献速递肝病消化道出血消化内镜

确定肝硬化急性静脉曲张出血患者早期TIPS的最佳候选者:一项多中心观察性研究

Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study.
PubMed 文献 · Gut · 2018-11-10

该多中心观察性研究纳入中国12所大学医院2010年12月至2016年6月连续收治的1425例肝硬化急性静脉曲张出血患者,其中206例接受早期TIPS,1219例接受标准治疗。在校正肝病严重程度等混杂因素后,早期TIPS与6周死亡风险降低80%(校正HR=0.20)及1年降低51%(校正HR=0.49)相关;生存获益见于MELD≥19或Child-Pugh C患者,而MELD≤11或Child-Pugh A患者未见获益。

要点

  • 早期TIPS与6周死亡风险降低80%(校正HR=0.20)及1年降低51%(校正HR=0.49)相关。
  • MELD≥19或Child-Pugh C患者观察到生存获益,MELD≤11或Child-Pugh A患者未观察到。
  • MELD 12-18患者6周内观察到生存获益但1年未观察到;Child-Pugh B伴活动性出血者观察到生存获益。

核心结论

  • 早期TIPS与MELD≥19或Child-Pugh C肝硬化患者生存改善相关,但与MELD≤11或Child-Pugh A患者生存改善无关。
  • 对于MELD 12-18或Child-Pugh B患者,未来仍高度需要针对早期TIPS最佳选择标准的研究。

研究设计与样本

  • 多中心观察性研究,收集中国12所大学医院2010年12月至2016年6月连续收治的1425例肝硬化急性静脉曲张出血患者数据。
  • 206例接受早期TIPS,1219例接受标准治疗。
  • 采用Fine和Gray竞争风险回归模型,在校正肝病严重程度和其他潜在混杂因素后,按现有风险分层系统分层比较两组结局。

主要发现

  • 分层分析中,各风险类别间死亡相对风险降低无显著差异,但高危患者死亡绝对风险降低更明显。
  • 6周死亡绝对风险降低在MELD≤11、12-18和≥19患者分别为-2.1%、-10.2%和-32.4%,在Child-Pugh A、B和C患者分别为-1.5%、-9.1%和-23.2%(交互检验,两项标准均p<0.001)。
  • 1年死亡绝对风险降低在MELD≤11、12-18和≥19患者分别为-1.7%、-5.4%和-32.7%,在Child-Pugh A、B和C患者分别为-3.6%、-5.2%和-20.3%(交互检验,两项标准均p<0.001)。
  • 校正肝病严重程度和其他潜在混杂因素后,MELD≥19或Child-Pugh C患者观察到生存获益,MELD≤11或Child-Pugh A患者未观察到;MELD 12-18患者6周内观察到生存获益但1年未观察到;Child-Pugh B患者中伴活动性出血者观察到生存获益而不伴活动性出血者未观察到。

关键数值与推荐

  • 6周死亡绝对风险降低:MELD≤11为-2.1%、MELD 12-18为-10.2%、MELD≥19为-32.4%;Child-Pugh A为-1.5%、Child-Pugh B为-9.1%、Child-Pugh C为-23.2%(交互检验均p<0.001)。
  • 1年死亡绝对风险降低:MELD≤11为-1.7%、MELD 12-18为-5.4%、MELD≥19为-32.7%;Child-Pugh A为-3.6%、Child-Pugh B为-5.2%、Child-Pugh C为-20.3%(交互检验均p<0.001)。

临床怎么用

  • 早期TIPS与MELD≥19或Child-Pugh C肝硬化患者生存改善相关,但与MELD≤11或Child-Pugh A患者生存改善无关。
  • 对于MELD 12-18或Child-Pugh B患者,未来仍高度需要针对早期TIPS最佳选择标准的研究。

局限性

  • 活动性出血的评估与较高的观察者间变异相关。
  • 对于MELD 12-18或Child-Pugh B患者,未来仍高度需要针对早期TIPS最佳选择标准的研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Early placement of transjugular intrahepatic portosystemic shunt (TIPS) has been shown to improve survival in high-risk patients (Child-Pugh B plus active bleeding at endoscopy or Child-Pugh C 10-13) with cirrhosis and acute variceal bleeding (AVB). However, early TIPS criteria may overestimate the mortality risk in a significant proportion of patients, and the survival benefit conferred by early TIPS in such patients has been questioned. Alternative criteria have been proposed to refine the criteria used to identify candidates for early TIPS. Nevertheless, the true survival benefit provided (or not) by early TIPS compared with standard treatment in the different risk categories has not been investigated in specifically designed comparative studies. DESIGN: We collected data on 1425 consecutive patients with cirrhosis and AVB who were admitted to 12 university hospitals in China between December 2010 and June 2016. Of these, 206 patients received early TIPS, and 1219 patients received standard treatment. The Fine and Gray competing risk regression model was used to compare the outcomes between the two groups that were stratified based on the currently available risk stratification systems after adjusting for liver disease severity and other potential confounders. RESULTS: Overall, early TIPS was associated with an 80% relative risk reduction (RRR) in mortality at 6 weeks (adjusted HR=0.20; 95% CI: 0.10 to 044; p<0.001) and 51% RRR at 1 year (adjusted HR=0.49, 95% CI: 0.32 to 0.73; p<0.001) compared with standard treatment. In stratification analyses, the RRRs in mortality did not significantly differ among the risk categories. However, the absolute risk reductions (ARRs) of mortality were more pronounced in high-risk patients. The ARRs at 6 weeks were -2.1%, -10.2% and -32.4% in Model for End-stage Liver Disease (MELD) ≤11, 12-18 and ≥19 patients and were -1.5%, -9.1% and -23.2% in Child-Pugh A, B and C patients, respectively (interaction tests, p<0.001 for both criteria). The ARRs for mortality at 1 year were -1.7%, -5.4% and -32.7% in MELD ≤11, 12-18 and ≥19 patients, respectively, and -3.6%, -5.2% and -20.3% in Child-Pugh A, B and C patients, respectively (interaction tests, p<0.001 for both criteria). After adjusting for liver disease severity and other potential confounders, a survival benefit was observed in MELD ≥19 or Child-Pugh C patients but not in MELD ≤11 or Child-Pugh A patients. In MELD 12-18 patients, a survival benefit was observed within 6 weeks but not at 1 year. In Child-Pugh B patients, a survival benefit was observed in those with active bleeding but not those without active bleeding. However, the evaluation of active bleeding was associated with a high interobserver variability. Furthermore, early TIPS was associated with a significantly reduced incidence of failure to control bleeding or rebleeding and new or worsening ascites, without increasing the risk of overt hepatic encephalopathy. CONCLUSIONS: Early TIPS was associated with improved survival in patients with MELD ≥19 or Child-Pugh C cirrhosis but not in patients with MELD ≤11 or Child-Pugh A cirrhosis. For MELD 12-18 or Child-Pugh B patients, future studies addressing optimal selection criteria for early TIPS remain highly warranted.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Lv Y, Zuo L, Zhu X, et al. Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study. Gut. 2018. PMID: 30415233. doi:10.1136/gutjnl-2018-317057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。